Cargando…
A cross‐sectional, prospective ocular motor study in 72 patients with Niemann‐Pick disease type C
OBJECTIVE: To characterize ocular motor function in patients with Niemann‐Pick disease type C (NPC). METHODS: In a multicontinental, cross‐sectional study we characterized ocular‐motor function in 72 patients from 12 countries by video‐oculography. Interlinking with disease severity, we also searche...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456972/ https://www.ncbi.nlm.nih.gov/pubmed/34096670 http://dx.doi.org/10.1111/ene.14955 |
_version_ | 1784570982383484928 |
---|---|
author | Bremova‐Ertl, Tatiana Abel, Larry Walterfang, Mark Salsano, Ettore Ardissone, Anna Malinová, Věra Kolníková, Miriam Gascón Bayarri, Jordi Reza Tavasoli, Ali Reza Ashrafi, Mahmoud Amraoui, Yasmina Mengel, Eugen Kolb, Stefan A. Brecht, Andreas Bardins, Stanislavs Strupp, Michael |
author_facet | Bremova‐Ertl, Tatiana Abel, Larry Walterfang, Mark Salsano, Ettore Ardissone, Anna Malinová, Věra Kolníková, Miriam Gascón Bayarri, Jordi Reza Tavasoli, Ali Reza Ashrafi, Mahmoud Amraoui, Yasmina Mengel, Eugen Kolb, Stefan A. Brecht, Andreas Bardins, Stanislavs Strupp, Michael |
author_sort | Bremova‐Ertl, Tatiana |
collection | PubMed |
description | OBJECTIVE: To characterize ocular motor function in patients with Niemann‐Pick disease type C (NPC). METHODS: In a multicontinental, cross‐sectional study we characterized ocular‐motor function in 72 patients from 12 countries by video‐oculography. Interlinking with disease severity, we also searched for ocular motor biomarkers. Our study protocol comprised reflexive and self‐paced saccades, smooth pursuit, and gaze‐holding in horizontal and vertical planes. Data were compared with those of 158 healthy controls (HC). RESULTS: Some 98.2% of patients generated vertical saccades below the 95% CI of the controls’ peak velocity. Only 46.9% of patients had smooth pursuit gain lower than that of 95% CI of HC. The involvement in both downward and upward directions was similar (51°/s (68.9, [32.7–69.3]) downward versus 78.8°/s (65.9, [60.8–96.8]) upward). Horizontal saccadic peak velocity and latency, vertical saccadic duration and amplitude, and horizontal position smooth pursuit correlated best to disease severity. Compensating strategies such as blinks to elicit saccades, and head and upper body movements to overcome the gaze palsy, were observed. Vertical reflexive saccades were more impaired and slower than self‐paced ones. Gaze‐holding was normal. Ocular‐motor performance depended on the age of onset and disease duration. CONCLUSIONS: This is the largest cohort of NPC patients investigated for ocular‐motor function. Vertical supranuclear saccade palsy is the hallmark of NPC. Vertical upward and downward saccades are equally impaired. Horizontal saccadic peak velocity and latency, vertical saccadic duration and amplitude, and horizontal position smooth pursuit can be used as surrogate parameters for clinical trials. Compensating strategies can contribute to establishing a diagnosis. |
format | Online Article Text |
id | pubmed-8456972 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84569722021-09-27 A cross‐sectional, prospective ocular motor study in 72 patients with Niemann‐Pick disease type C Bremova‐Ertl, Tatiana Abel, Larry Walterfang, Mark Salsano, Ettore Ardissone, Anna Malinová, Věra Kolníková, Miriam Gascón Bayarri, Jordi Reza Tavasoli, Ali Reza Ashrafi, Mahmoud Amraoui, Yasmina Mengel, Eugen Kolb, Stefan A. Brecht, Andreas Bardins, Stanislavs Strupp, Michael Eur J Neurol Infectious Diseases OBJECTIVE: To characterize ocular motor function in patients with Niemann‐Pick disease type C (NPC). METHODS: In a multicontinental, cross‐sectional study we characterized ocular‐motor function in 72 patients from 12 countries by video‐oculography. Interlinking with disease severity, we also searched for ocular motor biomarkers. Our study protocol comprised reflexive and self‐paced saccades, smooth pursuit, and gaze‐holding in horizontal and vertical planes. Data were compared with those of 158 healthy controls (HC). RESULTS: Some 98.2% of patients generated vertical saccades below the 95% CI of the controls’ peak velocity. Only 46.9% of patients had smooth pursuit gain lower than that of 95% CI of HC. The involvement in both downward and upward directions was similar (51°/s (68.9, [32.7–69.3]) downward versus 78.8°/s (65.9, [60.8–96.8]) upward). Horizontal saccadic peak velocity and latency, vertical saccadic duration and amplitude, and horizontal position smooth pursuit correlated best to disease severity. Compensating strategies such as blinks to elicit saccades, and head and upper body movements to overcome the gaze palsy, were observed. Vertical reflexive saccades were more impaired and slower than self‐paced ones. Gaze‐holding was normal. Ocular‐motor performance depended on the age of onset and disease duration. CONCLUSIONS: This is the largest cohort of NPC patients investigated for ocular‐motor function. Vertical supranuclear saccade palsy is the hallmark of NPC. Vertical upward and downward saccades are equally impaired. Horizontal saccadic peak velocity and latency, vertical saccadic duration and amplitude, and horizontal position smooth pursuit can be used as surrogate parameters for clinical trials. Compensating strategies can contribute to establishing a diagnosis. John Wiley and Sons Inc. 2021-07-12 2021-09 /pmc/articles/PMC8456972/ /pubmed/34096670 http://dx.doi.org/10.1111/ene.14955 Text en © 2021 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Infectious Diseases Bremova‐Ertl, Tatiana Abel, Larry Walterfang, Mark Salsano, Ettore Ardissone, Anna Malinová, Věra Kolníková, Miriam Gascón Bayarri, Jordi Reza Tavasoli, Ali Reza Ashrafi, Mahmoud Amraoui, Yasmina Mengel, Eugen Kolb, Stefan A. Brecht, Andreas Bardins, Stanislavs Strupp, Michael A cross‐sectional, prospective ocular motor study in 72 patients with Niemann‐Pick disease type C |
title | A cross‐sectional, prospective ocular motor study in 72 patients with Niemann‐Pick disease type C |
title_full | A cross‐sectional, prospective ocular motor study in 72 patients with Niemann‐Pick disease type C |
title_fullStr | A cross‐sectional, prospective ocular motor study in 72 patients with Niemann‐Pick disease type C |
title_full_unstemmed | A cross‐sectional, prospective ocular motor study in 72 patients with Niemann‐Pick disease type C |
title_short | A cross‐sectional, prospective ocular motor study in 72 patients with Niemann‐Pick disease type C |
title_sort | cross‐sectional, prospective ocular motor study in 72 patients with niemann‐pick disease type c |
topic | Infectious Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456972/ https://www.ncbi.nlm.nih.gov/pubmed/34096670 http://dx.doi.org/10.1111/ene.14955 |
work_keys_str_mv | AT bremovaertltatiana acrosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT abellarry acrosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT walterfangmark acrosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT salsanoettore acrosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT ardissoneanna acrosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT malinovavera acrosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT kolnikovamiriam acrosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT gasconbayarrijordi acrosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT rezatavasoliali acrosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT rezaashrafimahmoud acrosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT amraouiyasmina acrosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT mengeleugen acrosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT kolbstefana acrosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT brechtandreas acrosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT bardinsstanislavs acrosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT struppmichael acrosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT bremovaertltatiana crosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT abellarry crosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT walterfangmark crosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT salsanoettore crosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT ardissoneanna crosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT malinovavera crosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT kolnikovamiriam crosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT gasconbayarrijordi crosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT rezatavasoliali crosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT rezaashrafimahmoud crosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT amraouiyasmina crosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT mengeleugen crosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT kolbstefana crosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT brechtandreas crosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT bardinsstanislavs crosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec AT struppmichael crosssectionalprospectiveocularmotorstudyin72patientswithniemannpickdiseasetypec |